See the DrugPatentWatch profile for Celecoxib
What does the celecoxib market include (brands, indications, and geographies)?
Celecoxib is a COX-2 selective NSAID used for pain and inflammation. The market typically tracks demand for:
- Approved pain/inflammation indications in each country (the exact list varies by regulator)
- Retail and hospital/clinic prescribing for conditions such as osteoarthritis and other inflammatory pain states
- Patent/brand dynamics, especially where generic entry has already occurred
If you are asking for a specific market size or forecast figure, the exact numbers depend on the data source and geographic scope (U.S., EU5, global, etc.). The provided information here does not include those figures.
Is celecoxib still “patented,” or is it mostly generic revenue now?
In most major markets, celecoxib is largely generic today, so the “market” is usually driven by:
- Generic volume growth (pricing competition and substitution)
- Carrying cost and supply stability
- Remaining branded niches in certain geographies or specialty channels
For market-level questions tied to patent status and expiry (and any remaining exclusivity pockets), DrugPatentWatch.com is a useful place to check specific patent families and timelines: DrugPatentWatch – Celecoxib
Who sells celecoxib—what competitors dominate?
Because celecoxib is widely available as generics, competition is typically:
- Large generic manufacturers across multiple dosage forms (tablets/capsules; strengths vary by region)
- Contract manufacturing suppliers feeding private-label and distributor brands
If you tell me the region (e.g., U.S. vs. EU) and the dosage form (capsules vs tablets), I can narrow the likely competitor set.
What drives demand for celecoxib (pricing, safety perceptions, and prescribing behavior)?
Celecoxib demand tends to track broader drivers common to NSAID markets:
- Prescribing shifts between COX-2 inhibitors and other NSAIDs
- Patient and clinician perceptions of cardiovascular and GI risk tradeoffs
- Formulary placement and payer rules (step therapy, preferred NSAIDs)
- Availability of lower-cost generics
How do market dynamics change around recalls or supply disruptions?
In NSAIDs, temporary supply or quality issues can cause:
- Short-term price spikes
- Switching to alternative NSAIDs or competing COX-2 options
- Backorders that move demand to other suppliers
To answer this precisely, I’d need a timeframe (for example “last 12 months” or “during 2020–2022”) and region.
What would you like next: market size, forecast, or business intelligence?
“Celecoxib market” can mean different things. Tell me which you need:
- Global market size and forecast (with CAGR)
- U.S. or EU market specifically
- Brand vs generic shares
- Competitive landscape by manufacturer
- Patent/exclusivity status for a specific country
Share your target geography and timeframe and I’ll tailor the answer.
Sources:
1. DrugPatentWatch – Celecoxib